Logo image of AXA.DE

AXA SA (AXA.DE) Stock Fundamental Analysis

FRA:AXA - Deutsche Boerse Ag - FR0000120628 - Common Stock - Currency: EUR

41.56  +0.81 (+1.99%)

Fundamental Rating

5

Taking everything into account, AXA scores 5 out of 10 in our fundamental rating. AXA was compared to 38 industry peers in the Insurance industry. Both the profitability and the financial health of AXA get a neutral evaluation. Nothing too spectacular is happening here. AXA has a correct valuation and a medium growth rate. Finally AXA also has an excellent dividend rating. With these ratings, AXA could be worth investigating further for dividend investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

AXA had positive earnings in the past year.
In the past year AXA had a positive cash flow from operations.
AXA had positive earnings in each of the past 5 years.
In the past 5 years AXA always reported a positive cash flow from operatings.
AXA.DE Yearly Net Income VS EBIT VS OCF VS FCFAXA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

AXA has a Return On Assets of 1.18%. This is comparable to the rest of the industry: AXA outperforms 55.26% of its industry peers.
Looking at the Return On Equity, with a value of 15.39%, AXA is in the better half of the industry, outperforming 63.16% of the companies in the same industry.
AXA's Return On Invested Capital of 1.33% is in line compared to the rest of the industry. AXA outperforms 57.89% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AXA is in line with the industry average of 2.18%.
The 3 year average ROIC (1.29%) for AXA is below the current ROIC(1.33%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.18%
ROE 15.39%
ROIC 1.33%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
AXA.DE Yearly ROA, ROE, ROICAXA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

AXA has a Profit Margin (8.80%) which is in line with its industry peers.
AXA's Profit Margin has improved in the last couple of years.
The Operating Margin of AXA (12.32%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of AXA has grown nicely.
Industry RankSector Rank
OM 12.32%
PM (TTM) 8.8%
GM N/A
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
AXA.DE Yearly Profit, Operating, Gross MarginsAXA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AXA is destroying value.
The number of shares outstanding for AXA has been reduced compared to 1 year ago.
AXA has less shares outstanding than it did 5 years ago.
AXA has a worse debt/assets ratio than last year.
AXA.DE Yearly Shares OutstandingAXA.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
AXA.DE Yearly Total Debt VS Total AssetsAXA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B

2.2 Solvency

Based on the Altman-Z score of 0.35, we must say that AXA is in the distress zone and has some risk of bankruptcy.
AXA's Altman-Z score of 0.35 is amongst the best of the industry. AXA outperforms 89.47% of its industry peers.
The Debt to FCF ratio of AXA is 2.19, which is a good value as it means it would take AXA, 2.19 years of fcf income to pay off all of its debts.
AXA has a Debt to FCF ratio of 2.19. This is in the better half of the industry: AXA outperforms 68.42% of its industry peers.
AXA has a Debt/Equity ratio of 0.53. This is a neutral value indicating AXA is somewhat dependend on debt financing.
The Debt to Equity ratio of AXA (0.53) is better than 63.16% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 2.19
Altman-Z 0.35
ROIC/WACC0.13
WACC10.43%
AXA.DE Yearly LT Debt VS Equity VS FCFAXA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

AXA has a Current Ratio of 0.87. This is a bad value and indicates that AXA is not financially healthy enough and could expect problems in meeting its short term obligations.
With an excellent Current ratio value of 0.87, AXA belongs to the best of the industry, outperforming 84.21% of the companies in the same industry.
AXA has a Quick Ratio of 0.87. This is a bad value and indicates that AXA is not financially healthy enough and could expect problems in meeting its short term obligations.
AXA's Quick ratio of 0.87 is amongst the best of the industry. AXA outperforms 84.21% of its industry peers.
Industry RankSector Rank
Current Ratio 0.87
Quick Ratio 0.87
AXA.DE Yearly Current Assets VS Current LiabilitesAXA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.08% over the past year.
Measured over the past years, AXA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.09% on average per year.
The Revenue has been growing slightly by 4.38% in the past year.
AXA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.16% yearly.
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%

3.2 Future

Based on estimates for the next years, AXA will show a small growth in Earnings Per Share. The EPS will grow by 5.12% on average per year.
Based on estimates for the next years, AXA will show a small growth in Revenue. The Revenue will grow by 7.15% on average per year.
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y5.12%
Revenue Next Year6.2%
Revenue Next 2Y5.54%
Revenue Next 3Y2.73%
Revenue Next 5Y7.15%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AXA.DE Yearly Revenue VS EstimatesAXA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B 80B 100B
AXA.DE Yearly EPS VS EstimatesAXA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

AXA is valuated reasonably with a Price/Earnings ratio of 11.58.
Based on the Price/Earnings ratio, AXA is valued a bit cheaper than 71.05% of the companies in the same industry.
AXA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.54.
The Price/Forward Earnings ratio is 10.38, which indicates a very decent valuation of AXA.
AXA's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AXA is cheaper than 68.42% of the companies in the same industry.
AXA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 35.28.
Industry RankSector Rank
PE 11.58
Fwd PE 10.38
AXA.DE Price Earnings VS Forward Price EarningsAXA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, AXA is valued a bit cheaper than 60.53% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.68
EV/EBITDA N/A
AXA.DE Per share dataAXA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of AXA may justify a higher PE ratio.
PEG (NY)1
PEG (5Y)0.64
EPS Next 2Y9.13%
EPS Next 3Y8.44%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.04%, AXA is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.36, AXA pays a bit more dividend than its industry peers.
AXA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 5.04%

5.2 History

On average, the dividend of AXA grows each year by 8.12%, which is quite nice.
Dividend Growth(5Y)8.12%
Div Incr Years4
Div Non Decr Years4
AXA.DE Yearly Dividends per shareAXA.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

AXA pays out 57.97% of its income as dividend. This is a bit on the high side, but may be sustainable.
AXA's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP57.97%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
AXA.DE Yearly Income VS Free CF VS DividendAXA.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
AXA.DE Dividend Payout.AXA.DE Dividend Payout, showing the Payout Ratio.AXA.DE Dividend Payout.PayoutRetained Earnings

AXA SA

FRA:AXA (8/7/2025, 7:00:00 PM)

41.56

+0.81 (+1.99%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-01 2025-08-01
Earnings (Next)N/A N/A
Inst Owners33.99%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap92.08B
Analysts81.54
Price Target45.17 (8.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.04%
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP57.97%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.01%
PT rev (3m)4.34%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)0.19%
Valuation
Industry RankSector Rank
PE 11.58
Fwd PE 10.38
P/S 1.05
P/FCF 7.68
P/OCF 7.39
P/B 1.84
P/tB 3.36
EV/EBITDA N/A
EPS(TTM)3.59
EY8.64%
EPS(NY)4.01
Fwd EY9.64%
FCF(TTM)5.41
FCFY13.02%
OCF(TTM)5.63
OCFY13.54%
SpS39.42
BVpS22.54
TBVpS12.36
PEG (NY)1
PEG (5Y)0.64
Profitability
Industry RankSector Rank
ROA 1.18%
ROE 15.39%
ROCE 1.67%
ROIC 1.33%
ROICexc 1.37%
ROICexgc 1.79%
OM 12.32%
PM (TTM) 8.8%
GM N/A
FCFM 13.73%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexcg growth 3Y10.47%
ROICexcg growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 2.19
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.54%
Interest Coverage 1.72
Cash Conversion N/A
Profit Quality 156.03%
Current Ratio 0.87
Quick Ratio 0.87
Altman-Z 0.35
F-Score7
WACC10.43%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y5.12%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%
Revenue Next Year6.2%
Revenue Next 2Y5.54%
Revenue Next 3Y2.73%
Revenue Next 5Y7.15%
EBIT growth 1Y18.59%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year25.76%
EBIT Next 3Y11.02%
EBIT Next 5YN/A
FCF growth 1Y240.94%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y216.74%
OCF growth 3Y7.85%
OCF growth 5Y9.48%